Reported effects of psychedelic use on those with low well-being given various emotional states and social contexts
Natasha L. Mason, Patrick C. Dolder, Kim P. C. Kuypers
Drug Science Policy and Law January 1, 2020 DOI: 10.1177/2050324519900068 via OpenAlex
Summary
AI-generated from the abstractPsychedelics like LSD and psilocybin are most often used at home, while MDMA is more common at parties or festivals. Most people take these substances when already in a positive mood, and their mood stays positive or shifts to positive afterward. Individuals with low psychological well-being are more likely to experience a positive mood change after using LSD, psilocybin, or MDMA compared to those with normal well-being. Higher neuroticism scores are linked to both a greater likelihood of positive mood change and a greater likelihood of negative side effects. The findings suggest that psychedelic use can yield positive outcomes even in people with lower well-being and higher neuroticism.
Study at a glance
| Characteristics | Cross-sectional survey Peer reviewed |
|---|---|
| Sample size | 1,967 |
| Population | Online respondents who use psychedelics |
| Topics | LSD MDMA Psilocybin |
| Keywords | Mood Neuroticism Hallucinogen |
| Citations | 15 |
| Key finding | Individuals with low well-being and higher neuroticism scores are more likely to report positive mood changes after using LSD, psilocybin, or MDMA than those with normal well-being. |
Abstract
Background It has been suggested that the outcome of the psychedelic experience is dependent on set and setting. While scientific research into the therapeutic potential of psychedelics is growing, it is clear that in clinical populations an optimal set and setting will not always be attainable. It was aimed to assess under which emotional and environmental circumstances psychedelic users use psychedelics, and the outcome of use given clinical characteristics, defined as low well-being and higher rates of neuroticism. Methods Online respondents (N = 1967) provided information about their psychedelic use, environment they consume the substance in (setting), and mood state pre/post-substance (set). Based on subjective mental well-being, respondents were separated into two groups, those with low (N = 643), and those with normal well-being (N = 1324). Personality traits, with a particular focus on neuroticism, were also assessed. Results Findings showed that psychedelics such as lysergic acid diethylamide and psilocybin were most commonly used at home and methylenedioxymethamphetamine (MDMA) in a party/festival setting. In most instances, all substances were used when individuals were in a positive mood, and this remained in general positive, or, when not initially positive, shifted to positive, after use. Individuals with low well-being were more likely to experience a positive mood change after use of lysergic acid diethylamide, psilocybin or MDMA than individuals with normal well-being. Furthermore, as neuroticism scores increased, so did likelihood of positive mood change, as well as likelihood of experiencing negative side effects. Conclusion It is demonstrated that psychedelics are used in varying emotional states and environmental settings. Importantly in the light of future clinical studies with patients, individuals with low psychological well-being and higher scores of neuroticism report consuming such substances with positive outcomes.